These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28424333)

  • 1. Clinical chemoproteomics-Opportunities and obstacles.
    Jones LH; Neubert H
    Sci Transl Med; 2017 Apr; 9(386):. PubMed ID: 28424333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding chemogenomic space using chemoproteomics.
    Jones LH
    Bioorg Med Chem; 2019 Aug; 27(15):3451-3453. PubMed ID: 31221609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoproteomic profiling of protein-metabolite interactions.
    Qin W; Yang F; Wang C
    Curr Opin Chem Biol; 2020 Feb; 54():28-36. PubMed ID: 31812894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoproteomics: Towards Global Drug Target Profiling.
    Lu KY
    Chembiochem; 2020 Nov; 21(22):3189-3191. PubMed ID: 32935403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug target deconvolution by chemical proteomics.
    Raida M
    Curr Opin Chem Biol; 2011 Aug; 15(4):570-5. PubMed ID: 21763176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug discovery and molecular biological methods, via DNA, RNA and protein changes using structure-function transitions: Transitional structural chemogenomics, transitional structural chemoproteomics and novel multi-stranded nucleic acid microarray.
    Gagna CE; Lambert WC
    Med Hypotheses; 2006; 67(5):1099-114. PubMed ID: 16828979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of drug discovery: enabling technologies for enhancing lead characterization and profiling therapeutic potential.
    Janero DR
    Expert Opin Drug Discov; 2014 Aug; 9(8):847-58. PubMed ID: 24965547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in drug discovery.
    Hewick RM; Lu Z; Wang JH
    Adv Protein Chem; 2003; 65():309-42. PubMed ID: 12964374
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteomics profile of cellular response to chiral drugs: prospects for pharmaceutical applications.
    Bun Ching C; Zhang J; Sui J; Ning Chen W
    Proteomics; 2010 Feb; 10(4):888-93. PubMed ID: 19953539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoproteomics-driven drug discovery: addressing high attrition rates.
    Hall SE
    Drug Discov Today; 2006 Jun; 11(11-12):495-502. PubMed ID: 16713900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Methods in Chemoproteomics with Relevance to Drug Discovery.
    Nguyen C; West GM; Geoghegan KF
    Methods Mol Biol; 2017; 1513():11-22. PubMed ID: 27807827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping proteome-wide interactions of reactive chemicals using chemoproteomic platforms.
    Counihan JL; Ford B; Nomura DK
    Curr Opin Chem Biol; 2016 Feb; 30():68-76. PubMed ID: 26647369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural proteomics in drug discovery.
    Tari LW; Rosenberg M; Schryvers AB
    Expert Rev Proteomics; 2005 Aug; 2(4):511-9. PubMed ID: 16097885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoproteomic profiling of targets of lipid-derived electrophiles by bioorthogonal aminooxy probe.
    Chen Y; Cong Y; Quan B; Lan T; Chu X; Ye Z; Hou X; Wang C
    Redox Biol; 2017 Aug; 12():712-718. PubMed ID: 28411555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of Small Molecules by Chemical Proteomics.
    Huber KVM; Superti-Furga G
    Methods Mol Biol; 2016; 1394():211-218. PubMed ID: 26700051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry approaches to monitor protein-drug interactions.
    Zinn N; Hopf C; Drewes G; Bantscheff M
    Methods; 2012 Aug; 57(4):430-40. PubMed ID: 22687620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology, chemogenomics and chemoproteomics.
    Gagna CE; Winokur D; Clark Lambert W
    Cell Biol Int; 2004; 28(11):755-64. PubMed ID: 15563397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for the elucidation of protein-small molecule interactions.
    McFedries A; Schwaid A; Saghatelian A
    Chem Biol; 2013 May; 20(5):667-73. PubMed ID: 23706633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.